STOCK TITAN

Airsculpt Technologies (AIRS) Stock News

AIRS Nasdaq

Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.

AirSculpt Technologies, Inc. provides premium body contouring procedures through AirSculpt offices. Its AirSculpt method is a minimally invasive treatment for fat removal, skin tightening, targeted body sculpting, and fat transfer procedures that use a patient’s own fat cells.

Company news centers on operating results, same-center and same-store sales trends, case volume, revenue, adjusted EBITDA, guidance, marketing initiatives, new procedure categories, balance sheet activity, and governance changes. Updates also address the company’s positioning within aesthetics demand tied to GLP-1 use and its direct medical procedure services model.

Rhea-AI Summary

AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures, has announced its plans to report second quarter 2024 financial results. The company will release its earnings before the market opens on Friday, August 9, 2024, followed by a conference call at 8:30 a.m. Eastern Time on the same day.

Investors and interested parties can access the conference call by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871. Alternatively, they can request a return call for instant telephone access. A live webcast of the call will be available on the investor relations section of the AirSculpt Technologies website, with a replay accessible for approximately 90 days after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.08%
Tags
conferences earnings
-
Rhea-AI Summary

AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a 2.9% increase in first-quarter cases to 3,746 and a 3.9% revenue increase to $47.6 million. Net income rose to $6.0 million from a loss in the previous year. The company plans six new center openings in 2024 and maintains revenue guidance of $220 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.06%
Tags
-
Rhea-AI Summary

AirSculpt Technologies, Inc. announced its plans to release the first quarter 2024 financial results on May 10, 2024, followed by a conference call. The company specializes in premium body contouring procedures and invites investors to join the call for more information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
conferences earnings
Rhea-AI Summary

AirSculpt® Technologies, Inc., announced the relocation of its Atlanta office and the addition of the AirSculpt®+ skin tightening procedure to its offerings. The new office is in the prime Lenox Overlook area, and AirSculpt+ combines fat removal with skin tightening for enhanced results. The company has performed over 60,000 AirSculpt® cases since 2012 across premium locations in the U.S., Canada, and the U.K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.98%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.85%
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags

FAQ

What is the current stock price of Airsculpt Technologies (AIRS)?

The current stock price of Airsculpt Technologies (AIRS) is $4.76 as of May 18, 2026.

What is the market cap of Airsculpt Technologies (AIRS)?

The market cap of Airsculpt Technologies (AIRS) is approximately 338.6M.